Application | Comment | Organism |
---|---|---|
medicine | the enzyme activates a number of medically important nucleoside analogues | Drosophila melanogaster |
Crystallization (Comment) | Organism |
---|---|
purified recombinant enzyme, hanging drop vapour diffusion method, enzyme solution containing 10 mg/ml protein and 10 mM deoxycytidine, mixed with an equal volume of cyrstallization solution containing 0.1 M MES, pH 6.5, 0.2 M ammonium sulfate, 20% w/v PEG 5000, and 8-10% v/v PEG 400, X-ray diffraction structure determination and analysis at 2.6 A resolution, molecular replacement method | Drosophila melanogaster |
General Stability | Organism |
---|---|
ATP stabilizes the enzyme structure | Drosophila melanogaster |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | - |
Drosophila melanogaster |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Drosophila melanogaster | Q9XZT6 | - |
- |
Reaction | Comment | Organism | Reaction ID |
---|---|---|---|
ATP + a 2'-deoxyribonucleoside = ADP + a 2'-deoxyribonucleoside 5'-phosphate | substrate binding and interactions | Drosophila melanogaster |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + 2'-deoxycytidine | - |
Drosophila melanogaster | ADP + 2'-deoxycytidine 5'-phosphate | - |
? | |
additional information | the enzyme shows broad substrate specificity probably due to a wide substrate binding cleft | Drosophila melanogaster | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
dNK | - |
Drosophila melanogaster |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | stabilizes the enzyme structure, binding structure, Q111 and Arg118 are involved | Drosophila melanogaster |